Role of cephalosporins in the era of Clostridium difficile infection.

Wilcox, Mark H; Chalmers, James D; Nord, Carl E; Freeman, Jane; Bouza, Emilio

Wilcox, Mark H; Chalmers, James D; Nord, Carl E; Freeman, Jane; Bouza, Emilio.

Affiliation

Wilcox MH; Leeds Institute of Biomedical and Clinical Sciences, Faculty of Medicine and Health, University of Leeds, and Microbiology, Leeds Teaching Hospitals, Leeds, UK mark.wilcox@nhs.net.
Chalmers JD; Tayside Respiratory Research Group, University of Dundee, Dundee, UK.
Nord CE; Department of Laboratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
Freeman J; Leeds Institute of Biomedical and Clinical Sciences, Faculty of Medicine and Health, University of Leeds, and Microbiology, Leeds Teaching Hospitals, Leeds, UK.
Bouza E; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

J Antimicrob Chemother ; 72(1): 1-18, 2017 01.

Article in En | MEDLINE | ID: mdl-27659735

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cephalosporins / Clostridioides difficile / Clostridium Infections / Anti-Bacterial Agents Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Antimicrob Chemother Year: 2017 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google